Using the new treatment prevalence protocol in Ireland Suzi Lyons.

Slides:

Advertisements

Similar presentations

Dagmar Hedrich, Health and Social Responses EMCDDA expert meeting on TDI coverage, 5 February 2007 Treatment availability - ST 24 –

Advertisements

Treatment Demand Data: a breakdown by gender in some EU countries Linda Montanari, Colin Taylor, Lisbon, September 2004 Annual Expert Meeting on.

Delivering independent intelligence for health and wellbeing Background to NDTMS & TOP - a context for data collection Jill Smith Public Health Liaison.

A Pilot Study of Satisfaction and Adherence with Antipsychotic Medication Amongst Prisoners Dr Alice Mills Mr Dan Bressington Dr Richard Gray Professor.

Community Detoxification Initiative Ballymun March 2014 (Presented by Brian Foley)

HIV in British Columbia: Recent Trends Presentation for the Pacific AIDS Network February 25, 2009 Stephen Smith Manager, Blood-borne Pathogens.

Innovative Approaches to Screen School Populations for Sexually Transmitted Infections Paritosh Kaul, MD Douglas B Richardson Gerrit Bruintjes Cornelis.

STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.

The Relationship Between Repeat Infections and Behavioral Risk Factors and Clinician Counseling: Findings from a Philadelphia STD Clinic M. Eberhart 1,

Northamptonshire October 2010 – September Full calendar year Needle Exchange and Supervised Consumption.

Module 2: Data analysis key concepts. Module 2: Learning objectives  Understand the definition and purpose of data analysis  Define statistical and.

Interim analysis of a double- blind, placebo-controlled study with TMC207 in patients with Multi-Drug Resistant (MDR) Tuberculosis Karel de Beule, CDTL.

MENTAL HEALTH IN THE CRIMINAL JUSTICE SYSTEM The Perspective From The Irish Prison Service Fergal Black Director of Healthcare, Irish Prison Service Association.

Improving the Health and Social Well-being of Elderly Patients by Using Primary Care to Identify and Assist Those Who Are Failing to Claim Their Full Entitlement.

An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.

National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari,

Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,

California Outcomes Measurement System – Treatment

Attrition in HIV Care Attrition in HIV Care: Key Operational Challenge in implementing HIV Care and Treatment in Tanzania G R Somi _________ Ministry of.

ICAP HIV Testing and Counseling indicators Initial summary of data, January-March 2010 quarter ICAP.

Re-Screening of CT Positive Clients in Region X IPP, Goldenkranz S., 1 Fine D. 1 1 Center for Health Training 2010 CDC STD Prevention Meeting,

An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.

Finnish prison suicides from 1st January 2001 to 31st December 2010.

FHHS ACAT 2012/2013 Audit. A survey of prescribing in the frail elderly with reference to the STOPP criteria.

Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.

Decline in reported GC morbidity in NYC Preeti Pathela

Bill Edgar (University of Dundee UK) Barbara Illsley (University of Dundee UK) European Commission MPHASIS Mutual Progress on Homelessness through Advancing.

National Adult Inpatient Survey 2012 Presentation of survey results May /27/2015.

Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.

Vulnerable Groups & Risk of ill-treatment. Who is vulnerable to ill-treatment? Vulnerability to ill-treatment depends on Situation Characteristics of.

Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.

Ester Wina 24 July th IAC, Melbourne, Australia.

SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.

Chapter 6 Subset of Overview by Gender GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from

The University of Georgia Training and exposure to evidence-based practices: Changing attitudes among the addiction treatment workforce J. Aaron Johnson,

Inclusion of Women in Clinical Trials & Drug Development Regulatory Perspective Ameeta Parekh, Ph.D. R&D Director Office of Women’s Health Food & Drug.

Senior Drug Users: Scotland April Shaw & Austin Smith November 2009.

Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.

Treatment Prevalence Project Background information Expert meeting Implementation of the treatment strategy – Module 1: TDI prevalence 24 June 2013.

Predicting trends in fatal drug overdoses in Ireland: does day of the week matter? Simone Walsh, Ena Lynn and Suzi Lyons.

Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.

Poor linkage to care despite significant improvement in access to early cART – data from Test and Keep in Care (TAK) project. Leah Shepherd, Magdalena.

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) De Ridder Karin, Antoine.

Field Experience – Sri Lanka Field work 15 th July – 31 August 1 coordinator, 10 enumerators, 2 supervisors, data entry and verification staff Unedited.

General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,

Increasing Incidence of Gonorrhea in California (the talk formerly known as: “Gonorrhea Drips on in California”) Michael C Samuel 1, Virginia Loo 1, Denise.

ÖBIG Austrian Health Institute Gender Analysis and Women in Substitution Treatment in Austria Meeting on Treatment Demand Indicator EMCDDA 23 rd September.

Lisbon, June 2001 TDI working group A.W. Ouwehand 74.

A Pharmacokinetic Drug Interaction Study of Drug-72 and Drug-12 Department of Mathematic & Statistics York University Yufeng Lin Xiaofeng Zhou.

Barbara Illsley (University of Dundee UK) Volker Busch-Geertsema (GISS, Germany) European Commission MPHASIS Mutual Progress on Homelessness through Advancing.

Data quality and feedback from the assessment on 2000 and 2001 TDI data 1 EMCDDA, TDI meeting, 23/24 June 2003 Luis Royuela.

OBESITY 3.5. Facts…. NZ Make notes !!!!

Ethnic Monitoring: Improving Service Delivery? Dr Bobbie Jacobson Monitoring health and health care in the capital, supporting practitioners.

Characteristic Primary Cases Secondary Cases N= Median age in years (range) 57.5 (2-90)39 (9m-94) % of male cases 80% (78/97)56%

Hospital Episode Statistics (HES) Roy Maxwell (Senior Analyst) Tel: extn 307

Spirometry tests were carried out by a Respiratory Clinical Nurse Specialist (Respiratory CNS) Participants were referred to see their General Practitioner.

Cough WORKING GROUP MEETING

Abutment connect radiograph 12 month follow-up radiograph

Comparison of the study findings: Male & female

Equality Analysis Assessments

Data Cleansing Services - By INFOS B4B. What is a Data Cleansing Service? A Data Cleansing Service will amend incorrect or out of date data records within.

Treatment Prevalence Project Draft Guidelines

Registration of treatment demands for substance use disorders in Belgium : Why are some clients registered anonymously? Jérôme Antoine, Françoise Renard.

To recall the doubles of all numbers to at least 10

UK IT Industry Awards – UK Public Sector Project of the Year

National Overdose Deaths Number of Deaths from All Drugs

Professor Jack Lambert

1. What animal 2. Male or Female ? 4. Male or Female? Why? Why?

Public Health Implications

Presentation transcript:

Using the new treatment prevalence protocol in Ireland Suzi Lyons

Background issues 2 No unique health identifier in Ireland Two drug treatment databases: –National Drug Treatment Reporting System (NDTRS) which provides TDI data (episode based) –Central Treatment List (CTL) which records methadone treatment only (individual based)

Number of clients in methadone treatment in Ireland, May All clientsNew* Clinics General practice3632~ Prison626~ Total * New to methadone treatment ~ Numbers less than 10

Characteristics 4 69% male 28% aged 35 to 39 years 0.1% aged 16 to 19 years Males –27% years Females –29% years

What next? 5 Since 2008 NDTRS has collected exit data –Potential for national data –Problem of double counting Amend reporting mechanisms from CTL to allow full reporting at least for methadone treatment